Daniel Lule Bugembe

747 total citations
12 papers, 108 citations indexed

About

Daniel Lule Bugembe is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Daniel Lule Bugembe has authored 12 papers receiving a total of 108 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Virology and 6 papers in Molecular Biology. Recurrent topics in Daniel Lule Bugembe's work include HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS drug development and treatment (5 papers). Daniel Lule Bugembe is often cited by papers focused on HIV Research and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV/AIDS drug development and treatment (5 papers). Daniel Lule Bugembe collaborates with scholars based in Uganda, United Kingdom and United States. Daniel Lule Bugembe's co-authors include Matthew Cotten, My V. T. Phan, Pontiano Kaleebu, Hellen Nansumba, Áine O’Toole, Susan Nabadda, Andrew Rambaut, Isaac Ssewanyana, Susan Daniel and Gary R. Whittaker and has published in prestigious journals such as Emerging infectious diseases, Nature Microbiology and Viruses.

In The Last Decade

Daniel Lule Bugembe

10 papers receiving 107 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Lule Bugembe Uganda	5	99	32	20	10	8	12	108
Shan-Lu Liu United States	3	160 1.6×	39 1.2×	29 1.4×	12 1.2×	17 2.1×	3	180
Xiangyang Ge China	9	129 1.3×	54 1.7×	23 1.1×	7 0.7×	20 2.5×	22	166
Paul Zappile United States	8	76 0.8×	57 1.8×	10 0.5×	22 2.2×	19 2.4×	13	145
Anders Frische Denmark	5	81 0.8×	17 0.5×	29 1.4×	3 0.3×	12 1.5×	6	92
Shang Yu Gong Canada	6	83 0.8×	29 0.9×	11 0.6×	12 1.2×	13 1.6×	7	97
Krithika Muthuraman Canada	5	70 0.7×	36 1.1×	17 0.8×	9 0.9×	15 1.9×	6	103
Esther A. Bondzie United States	6	88 0.9×	19 0.6×	20 1.0×	31 3.1×	35 4.4×	11	125
Marcel Stern Germany	8	122 1.2×	46 1.4×	14 0.7×	11 1.1×	35 4.4×	12	170
Christin Mache Germany	6	53 0.5×	21 0.7×	11 0.6×	2 0.2×	10 1.3×	9	82
Silvia Renica Italy	3	74 0.7×	14 0.4×	7 0.3×	7 0.7×	3 0.4×	6	96

Countries citing papers authored by Daniel Lule Bugembe

Since Specialization

Citations

This map shows the geographic impact of Daniel Lule Bugembe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lule Bugembe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lule Bugembe more than expected).

Fields of papers citing papers by Daniel Lule Bugembe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lule Bugembe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lule Bugembe. The network helps show where Daniel Lule Bugembe may publish in the future.

Co-authorship network of co-authors of Daniel Lule Bugembe

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lule Bugembe. A scholar is included among the top collaborators of Daniel Lule Bugembe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lule Bugembe. Daniel Lule Bugembe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bugembe, Daniel Lule, Deogratius Ssemwanga, Pontiano Kaleebu, & Damien C. Tully. (2025). The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance. Microbial Genomics. 11(3).

Jjingo, Daudi, Nicholas Bbosa, Daniel Lule Bugembe, et al.. (2024). HIVseqDB: a portable resource for NGS and sample metadata integration for HIV-1 drug resistance analysis. Bioinformatics Advances. 4(1). vbae008–vbae008. 1 indexed citations

Bugembe, Daniel Lule, et al.. (2024). Next-Generation Sequencing Reveals a High Frequency of HIV-1 Minority Variants and an Expanded Drug Resistance Profile among Individuals on First-Line ART. Viruses. 16(9). 1454–1454.

Phan, My V. T., Daniel Lule Bugembe, Tiffany Tang, et al.. (2022). Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda. Microbiology Spectrum. 10(4). e0151422–e0151422. 26 indexed citations

Jjingo, Daudi, Nicholas Bbosa, Daniel Lule Bugembe, et al.. (2022). QuasiFlow: a Nextflow pipeline for analysis of NGS-based HIV-1 drug resistance data. Bioinformatics Advances. 2(1). vbac089–vbac089. 1 indexed citations

Bugembe, Daniel Lule, My V. T. Phan, Isaac Ssewanyana, et al.. (2021). Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda. Nature Microbiology. 6(8). 1094–1101. 47 indexed citations

Bugembe, Daniel Lule, My V. T. Phan, Lul Lojok Deng, et al.. (2021). SARS-CoV-2 Variants, South Sudan, January–March 2021. Emerging infectious diseases. 27(12). 3133–3136. 4 indexed citations

Phan, My V. T., Daniel Lule Bugembe, Tiffany Tang, et al.. (2021). Spike Protein Cleavage-Activation Mediated by the SARS-CoV-2 P681R Mutation: A Case-Study From Its First Appearance in Variant of Interest (VOI) A.23.1 Identified in Uganda. SSRN Electronic Journal. 7 indexed citations

Bugembe, Daniel Lule, et al.. (2020). Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort. BMC Infectious Diseases. 20(1). 172–172. 8 indexed citations

10.

Bugembe, Daniel Lule, Nicholas Bbosa, David Patrick Kateete, et al.. (2020). High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda. AIDS Research and Human Retroviruses. 36(9). 782–791. 2 indexed citations

11.

Bugembe, Daniel Lule, John Kayiwa, My V. T. Phan, et al.. (2020). Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda. Emerging infectious diseases. 26(10). 2411–2415. 9 indexed citations

12.

Bugembe, Daniel Lule, Kenneth Musinguzi, Christine Watera, et al.. (2015). Macrophage Inflammatory Protein-1 Beta and Interferon Gamma Responses in Ugandans with HIV-1 Acute/Early Infections. AIDS Research and Human Retroviruses. 32(3). 237–246. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact